Literature DB >> 33188909

Nanovaccine based on self-assembling nonstructural protein 1 boosts antibody responses to Zika virus.

Marianna Teixeira Pinho Favaro1, Monica Josiane Rodrigues-Jesus2, Alexia Adrianne Venceslau-Carvalho2, Rúbens Prince Dos Santos Alves2, Lennon Ramos Pereira2, Samuel Santos Pereira2, Robert Andreata-Santos2, Luís Carlos de Souza Ferreira3.   

Abstract

Self-assembling proteins may be generated after the addition of short specific amino acid sequences at both the N- and C-terminal ends. To date, this approach has not been evaluated regarding the impact of self-assembled proteins on the induction of immune responses. In the present study, we report the application of this experimental approach to the immunogenicity of protein antigens by measuring the antibody responses in mice immunized with nanoparticles made with a recombinant form of Zika virus nonstructural protein 1 (∆NS1). The results clearly indicated that ∆NS1-derived nanoparticles (NP-∆NS1) are assembled into a 3-dimensional structure with a high degree of multimerization. While ∆NS1 proved to be a weak immunogen, immunization with NP-∆NS1 enhanced subunit vaccines' immunogenicity with improved longevity in vaccinated mice. Thus, immunization with self-assembled antigens (nanovaccines) represents a new and promising strategy to enhance NS1-specific antibodies' induction based on purified recombinant proteins.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Nanoparticles; Nanovaccines; Nonstructural protein 1; Self-assembling protein nanoparticles; Vaccines; Zika virus

Mesh:

Substances:

Year:  2020        PMID: 33188909     DOI: 10.1016/j.nano.2020.102334

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  3 in total

1.  Self-Assembled Nanobodies as Selectively Targeted, Nanostructured, and Multivalent Materials.

Authors:  Laura Sánchez-García; Eric Voltà-Durán; Eloi Parladé; Elisa Mazzega; Alejandro Sánchez-Chardi; Naroa Serna; Hèctor López-Laguna; Mara Mitstorfer; Ugutz Unzueta; Esther Vázquez; Antonio Villaverde; Ario de Marco
Journal:  ACS Appl Mater Interfaces       Date:  2021-06-15       Impact factor: 10.383

2.  Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation.

Authors:  Monica Josiane Rodrigues-Jesus; Marianna Teixeira de Pinho Favaro; Aléxia Adrianne Venceslau-Carvalho; Maria Fernanda de Castro-Amarante; Bianca da Silva Almeida; Mariângela de Oliveira Silva; Robert Andreata-Santos; Cecilia Gomes Barbosa; Samantha Carvalho Maia Brito; Lucio H Freitas-Junior; Silvia Beatriz Boscardin; Luís Carlos de Souza Ferreira
Journal:  Nanomedicine       Date:  2022-08-27       Impact factor: 6.096

Review 3.  Recombinant vaccines in 2022: a perspective from the cell factory.

Authors:  Marianna Teixeira de Pinho Favaro; Jan Atienza-Garriga; Carlos Martínez-Torró; Eloi Parladé; Esther Vázquez; José Luis Corchero; Neus Ferrer-Miralles; Antonio Villaverde
Journal:  Microb Cell Fact       Date:  2022-10-05       Impact factor: 6.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.